Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com

Stock analysts at StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP) in a research note issued to investors on Wednesday. The firm set a “hold” rating on the stock.

Retractable Technologies Trading Down 1.5 %

NYSE RVP opened at $0.76 on Wednesday. The company’s 50-day simple moving average is $0.95 and its two-hundred day simple moving average is $1.05. Retractable Technologies has a one year low of $0.71 and a one year high of $1.34. The company has a market capitalization of $22.71 million, a price-to-earnings ratio of -2.92 and a beta of 2.08. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.54 and a current ratio of 9.51.

Retractable Technologies (NYSE:RVP) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($0.48) EPS for the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%. The business had revenue of $6.03 million during the quarter.

Insider Buying and Selling at Retractable Technologies

In other news, CEO Thomas J. Shaw purchased 71,422 shares of the stock in a transaction dated Friday, September 20th. The shares were acquired at an average cost of $0.82 per share, for a total transaction of $58,566.04. Following the acquisition, the chief executive officer now owns 14,743,907 shares of the company’s stock, valued at $12,090,003.74. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders have purchased 193,583 shares of company stock worth $181,695 over the last quarter. Insiders own 55.00% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.